← Evidence map

ReviewCurrent hematologic malignancy reports2019

The Rationale for Immunotherapy in Myeloproliferative Neoplasms.

Lucia Masarova et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31228096